Spark Therapeutics The company’s focus is on developing one-time, life-altering treatments for debilitating genetic diseases, a whole new model of personalized, precise treatment.

Dr. Steven M. Altschuler, who served 15 years as CEO of The Children’s Hospital of Philadelphia and is the co-founder of ...

Spark Therapeutics’ merger with Roche has moved a step closer after the UK’s competition watchdog okayed the $4.8 billion deal, ahead of a regulatory deadline later today in the US.

Spark Therapeutics is on the cusp of gaining the first ever approval for a gene therapy from the FDA, a groundbreaking treatment which restores vision to children and adults with a rare inherited ...

In a research note Spark Plus said Neurizon Therapeutics (ASX:NUZ) (formerly PharmAust) had a critical milestone in clinical ...

Science 2019-09-10T14:49:00Z $4.8 billion biotech Spark Therapeutics had to find a way to prove its first-of-its-kind treatment for eye disease actually worked. We got the inside story on how it ...

Victoria Nash - Drexel Graduate Co-op at Spark Therapeutics (1/3) Victoria Nash - Advice for Graduate Students in Biomedical Engineering (2/3) Victoria Nash - Benefits of Drexel Biomedical Engineering ...

Amplia Therapeutics Ltd. (AU:ATX) has released an update. Amplia Therapeutics Ltd. announces its plan to issue up to 5,433,750 new securities ...

Akari Therapeutics ( (AKTX) ) has issued an update. Akari Therapeutics recently secured shareholder approval for its merger with Peak Bio, a ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--egnite, Inc., a leading cardiovascular digital health company, today announced the ...

In addition to its treatment for a progressive form of blindness, the company has also been testing a way to combat hemophilia B, a blood clotting disorder, by intravenous treatment with viruses ...

HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine ...